Literature DB >> 30416663

The role and mechanism of miR-374 regulating the malignant transformation of mesenchymal stem cells.

Zixuan Sun1, Jingyan Chen1, Jiao Zhang1, Runbi Ji1,2, Wenrong Xu1, Xu Zhang1, Hui Qian1.   

Abstract

MicroRNAs (miRNAs) play important roles in cell transformation and carcinogenesis. We have previously established a tumor cell line K3 transformed from rat bone marrow-derived mesenchymal stem cells (rBM-MSCs). However, the underlying mechanism involved in MSC transformation remains unclear. Herein, we identified the key miRNAs that regulate the transformation of rBM-MSCs, and clarified their biological roles. Microarray and qRT-PCR results showed an increased expression of miR-374 but decreased expressions of miR-199a, miR-145, miR-34a, and miR-214 in K3 cells compared to rBM-MSCs. MiR-374 overexpression in rBM-MSCs increased the colony number and the proportion of the cells in S-phase. In addition, miR-374 overexpression reduced E-cadherin expression and increased N-cadherin expression in rBM-MSCs, promoting the migration ability of these cells. On the contrary, miR-374 knockdown in K3 cells led to impaired proliferation and migration capacities. Furthermore, wnt5a was identified as a target gene of miR-374. MiR-374 overexpression upregulated β-catenin expression in rBM-MSCs while miR-374 knockdown downregulated that in K3 cells. In conclusion, miR-374 promotes the proliferation and migration of transformed MSCs by regulating Wnt5a/β-catenin signaling pathway, which provides evidence for the contribution of miRNA to MSC transformation and suggests a new role of miR-374 in cancer development and progression.

Entities:  

Keywords:  MSC; malignant transformation; miR-374; wnt5a

Year:  2018        PMID: 30416663      PMCID: PMC6220215     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  23 in total

1.  A novel antagonist of CXCR4 prevents bone marrow-derived mesenchymal stem cell-mediated osteosarcoma and hepatocellular carcinoma cell migration and invasion.

Authors:  Raffaela Fontanella; Alessandra Pelagalli; Anna Nardelli; Crescenzo D'Alterio; Caterina Ieranò; Laura Cerchia; Enrico Lucarelli; Stefania Scala; Antonella Zannetti
Journal:  Cancer Lett       Date:  2015-10-27       Impact factor: 8.679

2.  Methylation status of the FHIT gene in the transformed human mesenchymal F6 stem cell line.

Authors:  Xue-Jing Xu; Shuo Gao; Mei Wang; Hui Qian; Guang-Yu Gu; Kui Zhang; Wen-Rong Xu
Journal:  Oncol Lett       Date:  2015-04-01       Impact factor: 2.967

3.  RSPO2 suppresses colorectal cancer metastasis by counteracting the Wnt5a/Fzd7-driven noncanonical Wnt pathway.

Authors:  Xiaoming Dong; Wanqin Liao; Li Zhang; Xi Tu; Jin Hu; Tianke Chen; Xiaowei Dai; Yan Xiong; Weicheng Liang; Chaodong Ding; Rui Liu; Juji Dai; Ouchen Wang; Liting Lu; Xincheng Lu
Journal:  Cancer Lett       Date:  2017-06-06       Impact factor: 8.679

4.  Wnt5a suppresses colon cancer by inhibiting cell proliferation and epithelial-mesenchymal transition.

Authors:  Runfen Cheng; Baocun Sun; Zhiyong Liu; Xiulan Zhao; Lisha Qi; Yixian Li; Qiang Gu
Journal:  J Cell Physiol       Date:  2014-12       Impact factor: 6.384

5.  Loss of interactions between p53 and survivin gene in mesenchymal stem cells after spontaneous transformation in vitro.

Authors:  Liu He; Fangyu Zhao; Yong Zheng; Yu Wan; Jian Song
Journal:  Int J Biochem Cell Biol       Date:  2016-03-30       Impact factor: 5.085

6.  MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer.

Authors:  Ying Zhang; Lu Guo; Yuhuan Li; Gui-Hai Feng; Fei Teng; Wei Li; Qi Zhou
Journal:  Mol Cancer       Date:  2018-01-05       Impact factor: 27.401

7.  Cancer stemness and metastatic potential of the novel tumor cell line K3: an inner mutated cell of bone marrow-derived mesenchymal stem cells.

Authors:  Hui Qian; Xiaoqing Ding; Jiao Zhang; Fei Mao; Zixuan Sun; Haoyuan Jia; Lei Yin; Mei Wang; Xu Zhang; Bin Zhang; Yongmin Yan; Wei Zhu; Wenrong Xu
Journal:  Oncotarget       Date:  2017-06-13

8.  MiR-199a/b-3p inhibits gastric cancer cell proliferation via down-regulating PAK4/MEK/ERK signaling pathway.

Authors:  Bin Zeng; Wei Shi; Gao Tan
Journal:  BMC Cancer       Date:  2018-01-05       Impact factor: 4.430

9.  Mesenchymal stromal cells induce epithelial-to-mesenchymal transition in human colorectal cancer cells through the expression of surface-bound TGF-β.

Authors:  Valentina Mele; Manuele G Muraro; Diego Calabrese; Dennis Pfaff; Nunzia Amatruda; Francesca Amicarella; Brynn Kvinlaug; Chiara Bocelli-Tyndall; Ivan Martin; Therese J Resink; Michael Heberer; Daniel Oertli; Luigi Terracciano; Giulio C Spagnoli; Giandomenica Iezzi
Journal:  Int J Cancer       Date:  2014-01-30       Impact factor: 7.396

10.  FOXC1-induced non-canonical WNT5A-MMP7 signaling regulates invasiveness in triple-negative breast cancer.

Authors:  Bingchen Han; Bo Zhou; Ying Qu; Bowen Gao; Yali Xu; Stacey Chung; Hisashi Tanaka; Wei Yang; Armando E Giuliano; Xiaojiang Cui
Journal:  Oncogene       Date:  2017-12-18       Impact factor: 9.867

View more
  4 in total

1.  MicroRNA-374 is a potential diagnostic biomarker for atherosclerosis and regulates the proliferation and migration of vascular smooth muscle cells.

Authors:  Weihong Wang; Fenghua Ma; Hongyan Zhang
Journal:  Cardiovasc Diagn Ther       Date:  2020-08

2.  miR-374a-5p: A New Target for Diagnosis and Drug Resistance Therapy in Gastric Cancer.

Authors:  Runbi Ji; Xu Zhang; Hongbing Gu; Jichun Ma; Xiangmei Wen; Jingdong Zhou; Hui Qian; Wenrong Xu; Jun Qian; Jiang Lin
Journal:  Mol Ther Nucleic Acids       Date:  2019-08-27       Impact factor: 8.886

Review 3.  TA-MSCs, TA-MSCs-EVs, MIF: their crosstalk in immunosuppressive tumor microenvironment.

Authors:  Zhenghou Zhang; Xiangyu Zhou; Jinshuai Guo; Fusheng Zhang; Yiping Qian; Guang Wang; Meiqi Duan; Yutian Wang; Haiying Zhao; Zhi Yang; Zunpeng Liu; Xiaofeng Jiang
Journal:  J Transl Med       Date:  2022-07-16       Impact factor: 8.440

Review 4.  Roles of Mesenchymal Stem Cell-Derived Exosomes in Cancer Development and Targeted Therapy.

Authors:  Zixuan Sun; Jiaxin Zhang; Jiali Li; Mi Li; Jing Ge; Peipei Wu; Benshuai You; Hui Qian
Journal:  Stem Cells Int       Date:  2021-07-10       Impact factor: 5.443

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.